Comprehensive treatment for the peritoneal metastasis from gastric cancer

doi:10.5412/wjsp.v5.i2.187

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14626)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-13) series, Tables (1-6) series.

Item

Count

PDF

615

WORD

491

HTML

6861

Figures (1-13)

536

Tables (1-6)

298

Sum=8801

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

997

Download

2458

Sum=3455

Publishing Process of This Article

Item

Count

Browse

1016

Download

1354

Sum=2370

Jul 28, 2015 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Surgical Procedures

ISSN

2219-2832

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Surg Proced. Jul 28, 2015; 5(2): 187-197
Published online Jul 28, 2015. doi: 10.5412/wjsp.v5.i2.187

Table 3 Histoloogic effects of primary tumor and peritoneal carcinomatosis in 41 patients after bidirectional intraperitoneal and systemic induction chemotherapy

	EF-0	EF-1	EF-2	EF-3	Total
Primary tumors	3 (12%)	15 (58%)	7 (27%)	1 (4%)	26 (100%)
Peritoneal metastasis	7 (17%)	18 (44%)	7 (17%)	9 (22%)	41 (100%)

EF-0: No histological change or histologic change is found in less than one-third of the tumor tissue; EF-1: Degeneration of cancer cells is detected in the tumor tissue ranging from one-third to less than two thirds; EF-2: The degeneration of cancer cells is found in more than two-thirds of the tumor tissue; EF-3: Complete disappearance of cancer cells.

Citation: Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Li Y, Liu Y, Takeshita K, Ichinose M, Takao N, Saitou T, Noguchi K, Hirano M, Glehen O, Brűcher B, Sugarbaker PH. Comprehensive treatment for the peritoneal metastasis from gastric cancer. World J Surg Proced 2015; 5(2): 187-197
URL: https://www.wjgnet.com/2219-2832/full/v5/i2/187.htm
DOI: https://dx.doi.org/10.5412/wjsp.v5.i2.187